FRAMOPTIC-D

This brand name is authorized in Nigeria.

Active ingredients

The drug FRAMOPTIC-D contains a combination of these active pharmaceutical ingredients (APIs):

1	Framycetin UNII Y3720KZ4TQ - FRAMYCETIN SULFATE
	Read more about Framycetin
2	Dexamethasone UNII AI9376Y64P - DEXAMETHASONE SODIUM PHOSPHATE
	Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response.
	Read more about Dexamethasone
3	Gramicidin UNII 5IE62321P4 - GRAMICIDIN
	Gramicidin is an antimicrobial cyclic polypeptide active in vitro against many gram positive bacteria like Bacillus subtilis and Staphylococcus aureus, but not well against gram-negative ones like E.coli.
	Read more about Gramicidin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-3468	Liquid	Framoptic-D Eye/Ear Drops (strength format) LIQ 5mg; 0.5mg; 0.05mg	Liquid 964 Framycetin Sulphate5.00 mg Dexamethasone Sodium Phosphate 0.5 mg, Gramicidin 0.05 mg 04-3468 Framoptic-D Eye/Ear Drops Framycetin Sulfate Dexamethasone Sodium Phosphate, Gramicidin Excipients: Ethyl Alcohol, Monobasic Sodium Phosphate Dibasic Sodium Phosphate Polysorbic Ml, Propylene Glacol Edetate Disodium Sodium Metabisulfite ., Sodium Chloride Phenylmercuric Nitrate, Purified Water Q.S. To Ml Ophthalmic Agents Ocular Route 5.0 mg, 0.5 mg, 0.05 mg. 0.005ml, 7.0 mg, 80 0.002ml, 3.0 mg, 1.0 mg, 1.5 mg, 3.0 mg, 0.02 mg, 1.0ml Liquid Prescription Only Medicine (Pom) Linkabs Pharmaceuticals Ltd Ashford Laborarories Ltd Macau 2021-09-28 2026-09-27	28/09/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S03CA01	Dexamethasone and antiinfectives	S Sensory organs → S03 Ophthalmological and otological preparations → S03C Corticosteroids and antiinfectives in combination → S03CA Corticosteroids and antiinfectives in combination
Discover more medicines within S03CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-3468